bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 460.07M |
| Enterprise value | 598.65M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 65.58 |
| Price/book (mrq) | 2.90 |
| Enterprise value/revenue | 116.47 |
| Enterprise value/EBITDA | -1.37 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.99 |
| 52-week change 3 | -10.32% |
| S&P500 52-week change 3 | -13.21% |
| 52-week high 3 | 8.5800 |
| 52-week low 3 | 2.8700 |
| 50-day moving average 3 | 5.6396 |
| 200-day moving average 3 | 6.0247 |
Share statistics
| Avg vol (3-month) 3 | 3.88M |
| Avg vol (10-day) 3 | 5.2M |
| Shares outstanding 5 | 102.92M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 82.18M |
| % held by insiders 1 | 1.09% |
| % held by institutions 1 | 67.24% |
| Shares short (14 Mar 2023) 4 | 20.51M |
| Short ratio (14 Mar 2023) 4 | 5.59 |
| Short % of float (14 Mar 2023) 4 | 25.00% |
| Short % of shares outstanding (14 Mar 2023) 4 | 19.93% |
| Shares short (prior month 14 Feb 2023) 4 | 17.32M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1544:1000 |
| Last split date 3 | 04 Nov 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -8,526.23% |
Management effectiveness
| Return on assets (ttm) | -29.46% |
| Return on equity (ttm) | -83.77% |
Income statement
| Revenue (ttm) | 5.14M |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | -93.00% |
| Gross profit (ttm) | -351.14M |
| EBITDA | -446.38M |
| Net income avi to common (ttm) | -431.14M |
| Diluted EPS (ttm) | -5.5700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 139.63M |
| Total cash per share (mrq) | 1.68 |
| Total debt (mrq) | 278.21M |
| Total debt/equity (mrq) | 175.13 |
| Current ratio (mrq) | 1.27 |
| Book value per share (mrq) | 1.92 |
Cash flow statement
| Operating cash flow (ttm) | -436.4M |
| Levered free cash flow (ttm) | -358.89M |
© 2023 Yahoo. All rights reserved.
